These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 22898358)

  • 1. An exploratory, randomized, crossover MRI study of microbicide delivery with the SILCS diaphragm compared to a vaginal applicator.
    Pentlicky S; Rosen M; Coffey PS; Kilbourne-Brook M; Shaunik A; Schreiber CA; Barnhart K
    Contraception; 2013 Feb; 87(2):187-92. PubMed ID: 22898358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Randomized Crossover Study Evaluating the Use and Acceptability of the SILCS Diaphragm Compared to Vaginal Applicators for Vaginal Gel Delivery.
    Beksinska M; Greener R; Smit J; Maphumulo B; Mphili N; Kilbourne-Brook M; Coffey PS
    AIDS Behav; 2018 Jan; 22(1):127-132. PubMed ID: 28993940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Couples' acceptability of the SILCS diaphragm for microbicide delivery.
    Frezieres RG; Walsh T; Kilbourne-Brook M; Coffey PS
    Contraception; 2012 Jan; 85(1):99-107. PubMed ID: 22067809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of a vaginal gel (Invisible Condom) before, during and after simulated sexual intercourse and its persistence when delivered by two different vaginal applicators: a magnetic resonance imaging study.
    Omar RF; Trottier S; Brousseau G; Lamarre A; Alexandre Gagnon ; Bergeron MG
    Contraception; 2008 Jun; 77(6):447-55. PubMed ID: 18477496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance imaging to determine the distribution of a vaginal gel: before, during, and after both simulated and real intercourse.
    Pretorius ES; Timbers K; Malamud D; Barnhart K
    Contraception; 2002 Dec; 66(6):443-51. PubMed ID: 12499038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, comparative safety study of a prefilled plastic and user-filled paper applicator with candidate microbicide tenofovir 1% gel.
    Cohen JA; Brache V; Foster J; Cochon L; Callahan M; Schwartz J
    Sex Transm Dis; 2013 Jun; 40(6):476-81. PubMed ID: 23677021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Universal vaginal applicator for the uniform distribution of vaginal gel and cream formulations: a magnetic resonance imaging study.
    Omar RF; Trottier S; Brousseau G; Ouellet C; Danylo A; Ong T; Bergeron MG
    J Obstet Gynaecol Can; 2014 Jan; 36(1):42-50. PubMed ID: 24444286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SILCS diaphragm: postcoital testing of a new single-size contraceptive device.
    Schwartz JL; Ballagh SA; Creinin MD; Rountree RW; Kilbourne-Brook M; Mauck CK; Callahan MM
    Contraception; 2008 Sep; 78(3):237-44. PubMed ID: 18692615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measuring adherence by visual inspection of returned empty gel applicators in the CAPRISA 004 microbicide trial.
    Gengiah TN; Mansoor LE; Upfold M; Naidoo A; Yende-Zuma N; Kashuba AD; Karim QA; Karim SS
    AIDS Behav; 2014 May; 18(5):820-5. PubMed ID: 24623069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic resonance imaging of SILCS diaphragm: anatomical considerations and corroboration with clinical fit.
    Yang CC; Maravilla KR; Kilbourne-Brook M; Austin G
    Contraception; 2007 Sep; 76(3):238-44. PubMed ID: 17707723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Pilot Study Measuring the Distribution and Permeability of a Vaginal HIV Microbicide Gel Vehicle Using Magnetic Resonance Imaging, Single Photon Emission Computed Tomography/Computed Tomography, and a Radiolabeled Small Molecule.
    Fuchs EJ; Schwartz JL; Friend DR; Coleman JS; Hendrix CW
    AIDS Res Hum Retroviruses; 2015 Nov; 31(11):1109-15. PubMed ID: 26077739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of microbicide gel adherence monitoring methods.
    Moench TR; O'Hanlon DE; Cone RA
    Sex Transm Dis; 2012 May; 39(5):335-40. PubMed ID: 22504592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acceptability of and Adherence to an Antiretroviral-Based Vaginal Microbicide among Pregnant Women in the United States.
    Montgomery ET; Noguchi LM; Dai JY; Pan J; Biggio J; Hendrix C; Isaacs K; Watts DH; Schwartz JL; Piper J; Beigi R
    AIDS Behav; 2018 Feb; 22(2):402-411. PubMed ID: 28550377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acceptability and feasibility of Micralax applicators and of methyl cellulose gel placebo for large-scale clinical trials of vaginal microbicides.
    Coetzee N; Blanchard K; Ellertson C; Hoosen AA; Friedland B
    AIDS; 2001 Sep; 15(14):1837-42. PubMed ID: 11579246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring microbicide gel use with real-time notification of the container's opening events: results of the CAPRISA Wisebag study.
    Gengiah TN; Upfold M; Naidoo A; Mansoor LE; Feldblum PJ; Abdool Karim Q; Abdool Karim SS
    AIDS Behav; 2014 May; 18(5):833-40. PubMed ID: 24643314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Appropriateness of hydroxyethylcellulose gel as a placebo control in vaginal microbicide trials: a comparison of the two control arms of HPTN 035.
    Richardson BA; Kelly C; Ramjee G; Fleming T; Makanani B; Roberts S; Musara P; Mkandawire N; Moench T; Coletti A; Soto-Torres L; Karim SA;
    J Acquir Immune Defic Syndr; 2013 May; 63(1):120-5. PubMed ID: 23334506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized trial to determine the distribution of four topical gel formulations in the human vagina.
    Barnhart K; Kulp JL; Rosen M; Shera DM
    Contraception; 2009 Apr; 79(4):297-303. PubMed ID: 19272499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rectal-specific microbicide applicator: evaluation and comparison with a vaginal applicator used rectally.
    Carballo-Diéguez A; Giguere R; Dolezal C; Bauermeister J; Leu CS; Valladares J; Rohan LC; Anton PA; Cranston RD; Febo I; Mayer K; McGowan I
    AIDS Behav; 2014 Sep; 18(9):1734-45. PubMed ID: 24858481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of a 3.5-mL (1.0%) C31G vaginal gel using magnetic resonance imaging.
    Barnhart KT; Pretorius ES; Timbers K; Shera D; Shabbout M; Malamud D
    Contraception; 2005 May; 71(5):357-61. PubMed ID: 15854637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delivery of microbicides to the vagina: difficulties reported with the use of three devices, adherence to use and preferences.
    Hardy E; Hebling EM; Sousa MH; Almeida AF; Amaral E
    Contraception; 2007 Aug; 76(2):126-31. PubMed ID: 17656182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.